Kyorin Pharmaceutical Co Aktie | Kurs, Dividende, Prognose & News | 4569.T | JP3247090008 | February 2026

Date	Kyorin Pharmaceutical Co Price
	1,649.00 undefined
	1,654.00 undefined
	1,648.00 undefined
	1,637.00 undefined
	1,635.00 undefined
	1,620.00 undefined
	1,614.00 undefined
	1,600.00 undefined
	1,624.00 undefined
	1,628.00 undefined
	1,640.00 undefined
	1,626.00 undefined
	1,606.00 undefined
	1,611.00 undefined
	1,620.00 undefined
	1,622.00 undefined
	1,630.00 undefined
	1,621.00 undefined
	1,599.00 undefined
	1,597.00 undefined

Date	Kyorin Pharmaceutical Co Revenue	Kyorin Pharmaceutical Co EBIT	Kyorin Pharmaceutical Co Net Income
2028e	128.61 B undefined	0 undefined	5.21 B undefined
2027e	127.83 B undefined	0 undefined	4.92 B undefined
2026e	127.96 B undefined	0 undefined	4.79 B undefined
2025	130.09 B undefined	12.55 B undefined	9.09 B undefined
2024	119.53 B undefined	6.01 B undefined	5.32 B undefined
2023	113.27 B undefined	5.12 B undefined	4.72 B undefined
2022	105.53 B undefined	5 B undefined	3.93 B undefined
2021	102.9 B undefined	5.77 B undefined	6.13 B undefined
2020	109.98 B undefined	7.49 B undefined	6.15 B undefined
2019	113.62 B undefined	8.96 B undefined	6.87 B undefined
2018	110.64 B undefined	8.81 B undefined	6.57 B undefined
2017	115.37 B undefined	10.41 B undefined	7.31 B undefined
2016	119.48 B undefined	19.64 B undefined	13.64 B undefined
2015	113.12 B undefined	14.74 B undefined	12.06 B undefined
2014	111.4 B undefined	17.61 B undefined	12.03 B undefined
2013	107.03 B undefined	17.95 B undefined	12.42 B undefined
2012	103.23 B undefined	14.46 B undefined	9.23 B undefined
2011	104.07 B undefined	16.44 B undefined	10.93 B undefined
2010	99.76 B undefined	13.26 B undefined	8.85 B undefined
2009	90.89 B undefined	8.95 B undefined	2.04 B undefined
2008	81.07 B undefined	5.87 B undefined	2.19 B undefined
2007	77.09 B undefined	8.05 B undefined	4.84 B undefined
2006	366 M undefined	143 M undefined	20 M undefined

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
2.68	0.05	0.02	8.26	5.62	4.85	13.98	17.14	15.26	18.6	18.31	17.56	18.82	9.72	9.06	9.36	8.26	8.35	5.22	6.91
-0.06	-0.01	0	4.78	4.79	4.11	3.21	2.67	2.51	2.87	3.22	3.05	3.73	3.62	3.64	2.94	3.22	3.56	3.71	3.84
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.85	-0.08	0.13	-6.71	-5.73	-5.89	-5.48	-12.14	-7.63	-8.59	-1.86	-11.87	-12.27	3.91	-1.43	-11.33	-3.44	-4.3	-2.99	-7.34
-2.42	-2.17	0.01	-1.32	-0.24	3.04	0.31	-0.86	-1.23	-1.34	-0.38	-2.35	0.87	-0.86	-0.82	-0.63	-0.36	-2.43	0.41	-1.48
69	44	15	33	37	63	63	51	48	21	11	6	17	29	24	64	75	68	66	66
0.86	0.1	-0.02	3.08	4.57	2.5	1.98	7.01	6.51	4.62	6.09	4.64	4.5	3.77	1.66	3.48	1.51	1.9	1.25	2.07
-0.65	-2.21	0.16	5.01	4.44	6.11	12.03	6.81	8.91	11.54	19.29	6.39	11.14	16.39	10.45	0.34	7.68	5.19	6.35	1.92
-981	-73	0	-3,644	-2,151	-1,581	-1,252	-1,500	-2,043	-6,316	-3,095	-5,855	-7,342	-2,645	-3,873	-4,369	-3,217	-5,124	-2,690	-9,405
0.8	1.53	0.22	-3.14	-6.14	-4.23	0.41	-1.81	-4.93	-7.19	-2.48	-1.36	0.65	-13.14	-6.04	14.94	-2.94	-4.26	-2.56	-6.28
1.78	1.6	0.22	0.5	-3.99	-2.65	1.67	-0.31	-2.88	-0.87	0.62	4.49	7.99	-10.5	-2.17	19.31	0.27	0.87	0.13	3.13
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.1	-0.27	-1.3	-0.35	1.17	2.11	-1.84	3.96	-4.04	-1.77	0.04	1.58	2.09	-0.95	0.07	18.59	-0.77	-0.57	-0.34	-0.35
0	-1,500	-4	-47	-90	-65	-33	-21	-12	-2	-1	-2,186	-458	-445	524	-40,839	0	0	0	0
-0.24	-2.02	-0.12	-2.63	-1.53	1.19	-3.29	0.2	-7.41	-5.13	-3.7	-5.23	-2.25	-5.72	-3.74	-27.32	-5.12	-4.92	-4.11	-3.36
0	0	1.29	0	0	0	0	0	-0	-0	-0	0	-0	-0	0	0	-0	-0	-0	-0
-139	-251	-106	-2,228	-2,606	-863	-1,418	-3,732	-3,357	-3,357	-3,736	-4,626	-3,876	-4,322	-4,325	-5,068	-4,346	-4,347	-3,767	-3,015
-0.09	-2.7	0.26	-0.74	-3.24	2.76	9.2	5.11	-3.45	-0.67	13.29	-0.1	9.32	-2.54	0.47	-12.06	-0.4	-4.03	-0.19	-7.47
-1,626	-2,286	160	1,361	2,292	4,529	10,774	5,306	6,870	5,228	16,198	537	3,795	13,740	6,581	-4,028	4,461	63	3,657	-7,481
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Kyorin Pharmaceutical Co Gross margin	Kyorin Pharmaceutical Co Profit margin	Kyorin Pharmaceutical Co EBIT margin	Kyorin Pharmaceutical Co Profit margin
2028e	45.77 %	0 %	4.05 %
2027e	45.77 %	0 %	3.85 %
2026e	45.77 %	0 %	3.75 %
2025	45.77 %	9.64 %	6.98 %
2024	43.01 %	5.02 %	4.45 %
2023	44.29 %	4.52 %	4.17 %
2022	46.85 %	4.74 %	3.73 %
2021	50.17 %	5.61 %	5.96 %
2020	51.86 %	6.81 %	5.59 %
2019	50.53 %	7.88 %	6.05 %
2018	55.65 %	7.96 %	5.94 %
2017	55.93 %	9.03 %	6.33 %
2016	60.36 %	16.43 %	11.42 %
2015	58.81 %	13.03 %	10.66 %
2014	61.36 %	15.81 %	10.79 %
2013	62.5 %	16.77 %	11.61 %
2012	64.23 %	14.01 %	8.94 %
2011	63.91 %	15.8 %	10.5 %
2010	62.43 %	13.29 %	8.87 %
2009	59.52 %	9.85 %	2.24 %
2008	60.35 %	7.24 %	2.7 %
2007	59.81 %	10.45 %	6.28 %
2006	100 %	39.07 %	5.46 %

Date	Kyorin Pharmaceutical Co Sales per Share	Kyorin Pharmaceutical Co EBIT per share	Kyorin Pharmaceutical Co Earnings per Share
2028e	2,145.32 undefined	0 undefined	86.86 undefined
2027e	2,132.19 undefined	0 undefined	82.11 undefined
2026e	2,134.46 undefined	0 undefined	79.94 undefined
2025	2,264.4 undefined	218.37 undefined	158.16 undefined
2024	2,082.82 undefined	104.64 undefined	92.73 undefined
2023	1,976.68 undefined	89.33 undefined	82.42 undefined
2022	1,841.72 undefined	87.31 undefined	68.62 undefined
2021	1,796.01 undefined	100.78 undefined	106.99 undefined
2020	1,919.9 undefined	130.71 undefined	107.34 undefined
2019	1,731.49 undefined	136.51 undefined	104.68 undefined
2018	1,502.32 undefined	119.59 undefined	89.26 undefined
2017	1,570.58 undefined	141.75 undefined	99.44 undefined
2016	1,614.28 undefined	265.29 undefined	184.27 undefined
2015	1,515.59 undefined	197.45 undefined	161.63 undefined
2014	1,485.33 undefined	234.76 undefined	160.33 undefined
2013	1,427.08 undefined	239.31 undefined	165.63 undefined
2012	1,376.43 undefined	192.85 undefined	123.08 undefined
2011	1,387.59 undefined	219.25 undefined	145.69 undefined
2010	1,330.19 undefined	176.83 undefined	117.97 undefined
2009	1,211.85 undefined	119.36 undefined	27.16 undefined
2008	1,080.93 undefined	78.23 undefined	29.19 undefined
2007	1,027.91 undefined	107.39 undefined	64.56 undefined
2006	4.95 undefined	1.93 undefined	0.27 undefined

Date	Kyorin Pharmaceutical Co Dividend
2028e	60.82 undefined
2027e	57.17 undefined
2007e	10 undefined
2026	89 undefined
2025	52 undefined
2024	52 undefined
2023	52 undefined
2022	65 undefined
2021	75 undefined
2020	75 undefined
2019	68 undefined
2018	58 undefined
2017	58 undefined
2016	52 undefined
2015	62 undefined
2014	50 undefined
2013	45 undefined
2012	45 undefined
2011	50 undefined
2010	19 undefined
2009	11.5 undefined
2008	35 undefined
2007e	10 undefined
2006	20 undefined

Date	Kyorin Pharmaceutical Co Payout ratio
2028e	70.02 %
2027e	69.62 %
2026e	69.42 %
2025	71.01 %
2024	68.45 %
2023	68.8 %
2022	75.78 %
2021	60.75 %
2020	69.87 %
2019	71.65 %
2018	76.18 %
2017	58.32 %
2016	31.48 %
2015	32.17 %
2014	38.67 %
2013	30.19 %
2012	36.56 %
2011	30.89 %
2010	42.38 %
2009	69.96 %
2008	39.41 %
2007	54.21 %
2006	11,111.11 %

Date	EPS estimate	Revenue Estimate	Quarterly report
5/9/2024	0	0	2024 Q4
2/5/2024	0	0	2024 Q3

%	Name	Stocks	Change
8.74946 %	Kopernik Global Investors, LLC	5,245,300	566,000
8.63784 %	Mykam Co.	5,178,384	235,384
4.69992 %	Lucius Co., Ltd.	2,817,600	600
3.42786 %	KYORIN Pharmaceutical Co., Ltd. Group Company	2,055,000	-9,000
3.25271 %	KK Banrina	1,950,000	0
3.25271 %	KK Achanzu	1,950,000	0
2.93578 %	KK Luces	1,760,000	0
2.67223 %	Kaken Pharmaceutical Co Ltd	1,602,000	0
2.28574 %	Amundi Japan Ltd.	1,370,301	0
2.08772 %	Nomura Asset Management Co., Ltd.	1,251,588	-16,900
1.88175 %	The Vanguard Group, Inc.	1,128,108	1,400
1.60967 %	Ono Pharmaceutical Co Ltd	965,000	0
1.55346 %	BlackRock Institutional Trust Company, N.A.	931,300	14,200
1.19424 %	Dimensional Fund Advisors, L.P.	715,947	1,300
1.15096 %	Kissei Pharmaceutical Co Ltd	690,000	0
0.94884 %	Nikko Asset Management Co., Ltd.	568,829	-13,900
0.91280 %	Daiwa Asset Management Co., Ltd.	547,226	-2,700
0.78098 %	Janus Henderson Investors	468,200	0
0.50181 %	Norges Bank Investment Management (NBIM)	300,836	-36,871
0.33528 %	Suzuken Co Ltd	201,000	0
0.33361 %	Medipal Holdings Corp	200,000	0
0.28618 %	Mitsubishi UFJ Asset Management Co., Ltd.	171,566	-500
0.28542 %	DFA Australia Ltd.	171,107	49,100
0.26839 %	CI Global Asset Management	160,902	11,009
0.21284 %	Ogihara (Minoru)	127,598	127,598
0.21012 %	Charles Schwab Investment Management, Inc.	125,969	-114
0.20033 %	Mercer Global Investments Management Ltd	120,100	0
0.19225 %	Dimensional Fund Advisors, Ltd.	115,254	0
0.18239 %	BlackRock Advisors (UK) Limited	109,340	1,400
0.17615 %	Allspring Global Investments, LLC	105,600	0
0.17382 %	California State Teachers Retirement System	104,207	9,900
0.15638 %	Mellon Investments Corporation	93,748	-7,100
0.15063 %	Martin Currie Investment Management Ltd.	90,300	90,300
0.12704 %	Ogihara (Yutaka)	76,163	5,400
0.11226 %	California Public Employees' Retirement System	67,300	-900
0.08340 %	Hokuyaku Takeyama Holdings Inc	50,000	0
0.06969 %	Nuveen LLC	41,781	0
0.06806 %	State Street Global Advisors (US)	40,800	400
0.06590 %	Asset Management One Co., Ltd.	39,509	-100
0.06505 %	SEI Investments Management Corporation	39,000	0
0.05816 %	Geode Capital Management, L.L.C.	34,868	-8,100
0.05521 %	Robeco Institutional Asset Management B.V.	33,100	0
0.03653 %	Handelsbanken Kapitalförvaltning AB	21,900	0
0.03598 %	Northern Trust Global Investments Limited	21,568	10,468
0.03536 %	KLP Kapitalforvaltning AS	21,200	0
0.03406 %	UBS Fund Management (Switzerland) AG	20,418	0
0.03353 %	Russell Investments Limited	20,100	0
0.02752 %	Zürcher Kantonalbank (Asset Management)	16,500	0
0.02686 %	Thrivent Asset Management, LLC	16,100	7,700
0.02352 %	Norinchukin Zenkyoren Asset Management Co., Ltd.	14,100	0
0.02285 %	UBS Asset Management (UK) Ltd.	13,700	0
0.02152 %	BlackRock Investment Management (UK) Ltd.	12,900	0
0.01921 %	Vanguard Investments Australia Ltd.	11,515	-4
0.01721 %	Florida State Board of Administration	10,320	-11
0.01668 %	Daito Pharmaceutical Co Ltd	10,000	0
0.01518 %	Legal & General Investment Management Ltd.	9,100	0
0.01334 %	BlackRock Asset Management Canada Limited	8,000	0
0.01218 %	American Century Investment Management, Inc.	7,300	0
0.00983 %	Amundi Asset Management, SAS	5,896	0
0.00940 %	Nissay Asset Management Corp.	5,638	1,061
0.00790 %	Sumitomo Mitsui DS Asset Management Company, Limited	4,737	-300
0.00717 %	Boston Partners	4,300	0
0.00524 %	State Street Global Advisors Ireland Limited	3,140	0
0.00417 %	Simplex Asset Management Co., Ltd.	2,500	-300
0.00400 %	Vanguard Global Advisers LLC	2,400	0
0.00267 %	UBS Asset Management (Switzerland)	1,600	0
0.00251 %	Sumitomo Mitsui Trust Asset Management Co., Ltd.	1,503	347
0.00150 %	Invesco Capital Management LLC	900	0
0.00133 %	Pictet Asset Management Ltd.	800	-5,500
0.00127 %	State Street Global Advisors (Japan) Co., Ltd.	763	763
0.00117 %	Dimensional Fund Advisors Canada ULC	700	0
0.00088 %	Meiji Yasuda Asset Management Company Ltd.	530	25
0.00067 %	Harris Associates L.P.	400	0
0.00050 %	Evli Fund Management Company Ltd.	300	0
0.00017 %	Fubon Asset Management Company Ltd.	100	0
0.00015 %	Ogihara (Kazuko)	88	88
0.00004 %	FIL Investment Management (Hong Kong) Limited	25	2
0.00001 %	Resona Asset Management Co., Ltd.	8	0
0.00001 %	Daiwa Asset Management (America) Ltd.	8	8
0 %	Quoniam Asset Management GmbH	0	-21,800
0 %	Shinkin Asset Management Co., Ltd.	0	-300
0 %	State Street Global Advisors (UK) Ltd.	0	-3,140
0 %	Acadian Asset Management LLC	0	-9,400
0 %	Sompo Asset Management Co.,Ltd.	0	-41,978
0 %	Northern Trust Investments, Inc.	0	-3,800
0 %	AllianceBernstein L.P.	0	-857
0 %	UBS Asset Management Switzerland AG	0	-2,400

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Nichi-iko Pharmaceutical	SupplierCustomer	0,84	0,92	0,81	0,71	0,30	0,83
Suzuken	SupplierCustomer	0,82	0,94	0,70	0,53	0,39	0,73
Medipal Holdings	SupplierCustomer	0,76	0,87	0,82	0,69	0,49	0,04
Toho	SupplierCustomer	0,75	0,90	-0,22	0,11	0,36	0,72
Nisshin Seifun Group	SupplierCustomer	0,73	0,81	0,54	0,36	0,31	-0,04
Medical Ikkou Group	SupplierCustomer	0,72	0,17	-0,16	-0,37	-0,28
ASKA Pharmaceutical	SupplierCustomer	0,62	0,96	0,35	0,35	0,37	0,51
Alfresa Holdings	SupplierCustomer	0,62	0,73	0,68	0,44	0,50	0,88
Resona	SupplierCustomer	0,51	0,87	0,47	0,54	0,36	-0,52
Teijin	SupplierCustomer	0,50	0,81	0,37	0,35	-0,10	0,43

What values and corporate philosophy does Kyorin Pharmaceutical Co represent?

Kyorin Holdings Inc represents values of integrity, innovation, and patient-centric approach. With a dedicated corporate philosophy, the company strives to contribute to improving the quality of life and healthcare services. Kyorin Holdings Inc prioritizes ethical business practices, ensuring transparency and trustworthiness in all its operations. Through continuous research and development, the company aims to deliver cutting-edge pharmaceutical and healthcare solutions. With a focus on patient well-being, Kyorin Holdings Inc fosters collaborations and partnerships to enhance medical advancements and positively impact society.

In which countries and regions is Kyorin Pharmaceutical Co primarily present?

Kyorin Holdings Inc is primarily present in Japan.

What significant milestones has the company Kyorin Pharmaceutical Co achieved?

Kyorin Holdings Inc, a renowned company in the stock market, has achieved significant milestones throughout its history. With a strong commitment to excellence, Kyorin Holdings Inc has successfully expanded its portfolio and established a solid presence in various sectors. Notably, the company has achieved remarkable growth in the pharmaceutical industry, introducing innovative drugs and improving healthcare services. By leveraging its expertise and strategic partnerships, Kyorin Holdings Inc has consistently delivered impressive financial results, enhancing shareholder value and solidifying its position as a market leader. Through its continuous efforts in research and development, Kyorin Holdings Inc stands as a testament to its unwavering dedication to progress and success.

What is the history and background of the company Kyorin Pharmaceutical Co?

Kyorin Holdings Inc is a renowned Japanese pharmaceutical company with a rich history and solid background. Established in 1947, Kyorin Holdings Inc has been at the forefront of medical innovation, delivering high-quality healthcare products and services to customers worldwide. With a focus on research and development, Kyorin Holdings Inc has earned a stellar reputation in the industry for its dedication to advancing medical solutions. Over the years, the company has expanded its portfolio to include a diverse range of therapeutic areas, ranging from respiratory products to antiallergic medications. Kyorin Holdings Inc continues to strive for excellence in the healthcare sector, driven by its commitment to improving the well-being and quality of life for patients globally.

Who are the main competitors of Kyorin Pharmaceutical Co in the market?

Kyorin Holdings Inc faces competition from various companies in the market. Some of the main competitors of Kyorin Holdings Inc include Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, and Daiichi Sankyo Company, Limited. These companies operate in the same industry and offer similar products and services. However, Kyorin Holdings Inc has its unique strengths and is known for its innovative approach, superior quality, and strong customer base. With its strong presence and strategic initiatives, Kyorin Holdings Inc continues to thrive in the competitive market, ensuring sustainable growth and delivering value to its stakeholders.

In which industries is Kyorin Pharmaceutical Co primarily active?

Kyorin Holdings Inc is primarily active in the pharmaceutical and healthcare industries.

What is the business model of Kyorin Pharmaceutical Co?

Kyorin Holdings Inc, a leading pharmaceutical company based in Japan, primarily focuses on the research, development, manufacturing, and sales of pharmaceutical products. Their business model entails a comprehensive approach that spans across the entire pharmaceutical value chain. Kyorin Holdings Inc leverages its expertise to deliver innovative and high-quality drugs, targeting various medical areas such as respiratory diseases, allergies, infectious diseases, and more. By combining advanced research and development capabilities with a strong sales and marketing network, Kyorin Holdings Inc strives to enhance people's health and well-being through the provision of effective and safe pharmaceutical solutions.

What is the P/E ratio of Kyorin Pharmaceutical Co 2026?

The Kyorin Pharmaceutical Co P/E ratio is 19.77.

What is the P/S ratio of Kyorin Pharmaceutical Co 2026?

The Kyorin Pharmaceutical Co P/S ratio is 0.74.

What is the Quality Investing of Kyorin Pharmaceutical Co?

The Quality Investing for Kyorin Pharmaceutical Co is 4/10.

What is the revenue of Kyorin Pharmaceutical Co 2026?

The expected Kyorin Pharmaceutical Co revenue is 127.96 B JPY.

How high is the profit of Kyorin Pharmaceutical Co 2026?

The expected Kyorin Pharmaceutical Co profit is 4.79 B JPY.

What is the business model of Kyorin Pharmaceutical Co

Kyorin Holdings Inc. is a Japanese company that operates in various business sectors. The company was founded in 1950 and is headquartered in Tokyo, Japan. Kyorin Holdings Inc. is listed on the Tokyo Stock Exchange and also operates internationally. The company operates in three main business areas: pharmaceuticals, life science, and investment. In the pharmaceutical business sector, the company develops and distributes a wide range of prescription and over-the-counter drugs. Kyorin Holdings Inc. has its own production facility in Kashima, Japan, where these products are manufactured. The company focuses on cardiovascular, respiratory, urology, dermatology, and allergy areas. Some of the well-known products include the respiratory medication Eucrisa and the heart medication Inderal. In the life science sector, Kyorin Holdings Inc. operates a wide range of biotechnology and diagnostic companies. The company invests heavily in research and development to develop innovative products and technologies. Some of the well-known brands include the biotechnology company Kainos Medicine and the diagnostics company Paraxel. Kyorin Holdings Inc. also invests in other companies and operates an investment business sector. The company operates globally and focuses on various industries such as biotechnology, IT, financial services, and real estate. Kyorin Holdings Inc. also has a subsidiary called Kyorin Venture Capital, which specializes in supporting startups and their financing. To understand Kyorin Holdings Inc.'s business model, it is important to understand that the company has a diversified portfolio focusing on three main business areas. The company strives to be a leading provider in each of its sectors and to grow through research and development. Kyorin Holdings Inc. also has a clear growth strategy, focusing on global expansion and tapping into new markets. The company builds partnerships with other pharmaceutical and biotech companies to expand its market-leading position. Conclusion: Kyorin Holdings Inc.'s business model is focused on being a leading provider of pharmaceuticals, biotechnology products, and investment services. The company aims to continuously grow through research and development and expand into new markets through partnerships and strategic investments.

What is the Kyorin Pharmaceutical Co dividend?

Kyorin Pharmaceutical Co pays a dividend of 52 JPY distributed over payouts per year.

How often does Kyorin Pharmaceutical Co pay dividends?

The dividend cannot currently be calculated for Kyorin Pharmaceutical Co or the company does not pay out a dividend.

What is the Kyorin Pharmaceutical Co ISIN?

The ISIN of Kyorin Pharmaceutical Co is JP3247090008.

What is the Kyorin Pharmaceutical Co ticker?

The ticker of Kyorin Pharmaceutical Co is 4569.T.

How much dividend does Kyorin Pharmaceutical Co pay?

Over the past 12 months, Kyorin Pharmaceutical Co paid a dividend of 52 JPY . This corresponds to a dividend yield of about 3.15 %. For the coming 12 months, Kyorin Pharmaceutical Co is expected to pay a dividend of 57.17 JPY.

What is the dividend yield of Kyorin Pharmaceutical Co?

The current dividend yield of Kyorin Pharmaceutical Co is 3.15 %.

When does Kyorin Pharmaceutical Co pay dividends?

Kyorin Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of , , , .

How secure is the dividend of Kyorin Pharmaceutical Co?

Kyorin Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kyorin Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 57.17 JPY are expected. This corresponds to a dividend yield of 3.47 %.

In which sector is Kyorin Pharmaceutical Co located?

Kyorin Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kyorin Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kyorin Pharmaceutical Co from amounting to 37 JPY, you needed to have the stock in your portfolio before the ex-date on .

When did Kyorin Pharmaceutical Co pay the last dividend?

The last dividend was paid out on .

What was the dividend of Kyorin Pharmaceutical Co in the year 2025?

In the year 2025, Kyorin Pharmaceutical Co distributed 52 JPY as dividends.

In which currency does Kyorin Pharmaceutical Co pay out the dividend?

The dividends of Kyorin Pharmaceutical Co are distributed in JPY.

2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025

0.17	0.36	0.4	4.79	0.17	14.7	13.86	12.86	15.72	25.55	32.49	28.99	33.04	48.98	48.52	51.7	48.63	44.72	32.51	32.92	30.84	27.49	19.39	13.99	16.51
0.04	0.05	0.04	0.19	0	26.7	31.43	28.9	35.48	36.79	42.53	45.01	46.5	44.07	46.95	48.25	46.15	47.82	52.59	47.41	40.41	40.12	45.43	47.7	46.02
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.52	1.82	0	1.52
0.06	0.07	0.08	1.75	0	13.77	14.61	19.77	18.19	21.87	20.36	20.74	19.94	21.7	25.93	27.67	24.38	23.31	25.42	33.28	38.57	42.22	48.03	53.4	65.73
0.01	0	0	0.34	0.02	4.55	4.95	4.49	5.75	6.85	9.04	5.12	8.79	6.89	7.67	10.87	7.12	4.1	4.39	3.45	4.21	5.03	4.36	4.16	6.35
0.29	0.48	0.52	7.06	0.18	59.72	64.86	66.01	75.14	91.06	104.42	99.85	108.27	121.64	129.06	138.48	126.27	119.95	114.9	117.06	114.03	116.38	119.03	119.24	136.13
0.93	2.28	2.43	3.1	0	21.36	19.64	18.21	17.12	15.83	14.92	14.54	18.21	20.84	19.37	22.79	22.43	21.9	21.79	22.72	23.9	24.33	25.83	28.95	30.3
5.34	5.53	5.53	27.94	2.94	28.63	30.07	30.69	23.53	23.78	21.66	26.04	24.55	23.8	31.01	33.46	40.65	50.72	29.8	25.87	23.65	25.7	22.98	22.11	20.04
0	0	20	73	0	91	63	57	30	27	23	24	19	4	3	0	2	4	4	3	0	0	0	0	0
0	0	0	0.27	0	4.63	2.5	1.36	0.68	0.47	0.48	0.65	0.85	1.2	1.18	1.2	1.2	1.75	3.4	3.33	3.79	3.29	5.39	5.09	4.76
0	0	0	0.14	0	1.09	1.61	1	0.95	0.55	0.34	0.19	0.06	0	0	0	0	0	0	0	0	0	0	0	0
0.02	0.02	0.02	1.31	0	5.83	5.29	5.06	7.1	5.47	5.39	4.37	3.01	1.89	2.75	1.89	2.12	2.42	3.13	2.18	1.77	2.22	2.81	2.24	2.38
6.29	7.84	8	32.84	2.94	61.63	59.18	56.38	49.41	46.12	42.8	45.82	46.7	47.74	54.32	59.34	66.4	76.79	58.13	54.1	53.1	55.55	57.02	58.39	57.48
6.58	8.32	8.52	39.9	3.13	121.35	124.03	122.39	124.55	137.18	147.23	145.67	154.97	169.38	183.38	197.82	192.67	196.74	173.03	171.16	167.13	171.92	176.05	177.63	193.62

14	14	14	14	14	700	700	700	700	700	700	700	700	700	700	700	700	700	700	700	700	700	700	700	700
3.31	3.31	3.31	3.31	0.49	4.76	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75	4.75
3.12	3.47	3.53	29.02	1.31	88.26	91.56	91.13	92.31	99.74	106.93	112.8	121.86	130.15	137.58	147.33	150.3	152.54	129	130.79	132.56	132.71	134.4	136.73	142.79
0	0	0	0	0	42	56	37	-159	-134	-232	-266	-179	-885	284	-3,131	-2,393	-2,292	-2,274	-2,746	-2,316	-2,252	-2,416	-19	-151
0.05	0.04	0.04	0.62	0	1.18	1.2	0.75	-0.85	0.14	-0.14	0.54	2.29	3.43	7.8	0	7.65	10.1	8.93	6.92	6.64	6.27	5.7	5.93	5.54
6.5	6.84	6.89	32.97	1.81	94.94	98.27	97.37	96.75	105.19	112.01	118.52	129.42	138.15	151.11	149.65	161.01	165.8	141.1	140.42	142.33	142.18	143.13	148.09	153.63
0.01	0.01	0	1.56	0	6.59	9.69	10.79	8.26	9.86	10.85	9.04	8.56	11.06	11.26	11.79	11.16	10.27	11.44	9.78	6.99	10.9	13.76	14.27	15.52
0	0	0	0.06	0	2.33	2.13	2.24	2.56	3.04	3.22	3.11	3.33	3.3	3.29	3.25	2.69	2.38	2.24	2.33	2.21	2.3	2.18	2.2	2.23
0.01	0.02	0.01	0.37	0.01	8.68	7.43	4.64	6.69	10.44	9.31	8.03	9.29	12.16	11.65	10.91	9.61	11.26	6.61	8.48	7.55	8.36	8.43	8.73	9.49
0	1.4	0.13	1.5	0.13	0.77	0.69	1.53	4.15	2.49	6.7	2.86	1.18	1.37	1.13	1.23	0.63	0.13	20.1	10.1	10.1	10.1	10.1	10.1	7.4
0	0	0	0	0	0	0	0	0.06	0.37	0.34	0.34	0.54	0.52	0.45	0.87	0.95	1.1	1.08	0.64	0.56	0.53	0.51	10.2	0.48
0.02	1.43	0.15	3.49	0.14	18.37	19.94	19.2	21.71	26.19	30.42	23.39	22.9	28.4	27.77	28.05	25.03	25.13	41.48	31.33	27.41	32.18	34.98	45.49	35.11
0	0	1.42	2.28	1.17	1.13	0.8	1.13	1.13	0.64	0.46	0.36	0.18	0.26	0.28	0.54	0.48	0.41	3.01	13.05	11.45	11.18	10.84	0.44	20.7
0.04	0.03	0.03	0.04	0	0	0	0	0	0	0	0	0	0	2.82	2.61	2.07	1.26	2.06	0.2	0.29	0.18	0	0.18	0.06
0.02	0.02	0.03	1.08	0	6.35	5.12	4.88	5.2	5.44	4.64	3.73	2.79	2.9	3.92	9.57	7.25	6.64	3.09	3.87	3.32	3.88	4.76	0.79	1.46
0.06	0.05	1.48	3.4	1.17	7.48	5.92	6.01	6.33	6.08	5.1	4.09	2.97	3.16	7.01	12.72	9.8	8.31	8.16	17.12	15.06	15.24	15.6	1.4	22.22
0.08	1.48	1.62	6.89	1.31	25.84	25.86	25.21	28.05	32.27	35.52	27.47	25.87	31.56	34.78	40.78	34.83	33.44	49.64	48.45	42.47	47.42	50.58	46.89	57.33
6.58	8.32	8.52	39.85	3.13	120.78	124.13	122.58	124.8	137.47	147.53	145.99	155.29	169.7	185.89	190.43	195.84	199.24	190.74	188.87	184.8	189.6	193.71	194.98	210.97

Kyorin Pharmaceutical Co Ticker	Kyorin Pharmaceutical Co FIGI
4569:JP	BBG000N1VD71
4569:JT	BBG000N1VDS8
4569:JJ	BBG000N1WM52
4569:JE	BBG000N1WPJ0
4569:JI	BBG000N1WQ08
KYRNF:US	BBG000NP05C3
KYRNF:PQ	BBG000NP1J32
KYRNF:UV	BBG000NP1JN0
4569:JU	BBG002QKFJH6
4569:JW	BBG00875JKG1
4569JPY:XS	BBG00KR59YP3
4569JPY:XH	BBG00KR59YS0
4569JPY:XF	BBG00KR59YV6
4569JPY:XE	BBG00KR59YX4
4569JPY:XJ	BBG00KR59YY3
4569JPY:XL	BBG00KR59YZ2
4569JPY:XG	BBG00KR59Z07
4569JPY:XO	BBG00KR59Z16
4569JPY:XA	BBG00KR59Z52
4569JPY:E1	BBG00KR59Z61
4569JPY:XT	BBG00KR59Z70
4569JPY:XW	BBG00KR59Z89
4569JPY:XU	BBG00KR59Z98
4569JPY:XV	BBG00KR59ZB5
4569JPY:XM	BBG00KR59ZC4
4569JPY:XQ	BBG00KR59ZF1
4569JPY:XX	BBG00KR59ZG0
4569JPY:XZ	BBG00KR59ZH9
4569JPY:EU	BBG00KR59ZK5
4569JPY:EP	BBG00T0771B8
4569JPY:EZ	BBG00T0771D6
4569:JV	BBG0193RBSJ2

2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e	2027e	2028e
0.18	0.23	0.2	9.82	3.38	0.37	77.09	81.07	90.89	99.76	104.07	103.23	107.03	111.4	113.12	119.48	115.37	110.64	113.62	109.98	102.9	105.53	113.27	119.53	130.09	127.96	127.83	128.61
-	27.78	-11.30	4,715.20	-65.61	-89.17	20,963.66	5.16	12.11	9.76	4.32	-0.80	3.68	4.08	1.54	5.62	-3.44	-4.10	2.69	-3.20	-6.44	2.56	7.33	5.53	8.83	-1.63	-0.11	0.62
52.78	52.17	55.39	35.57	36.23	100.00	59.81	60.35	59.52	62.43	63.91	64.23	62.50	61.36	58.81	60.36	55.93	55.65	50.53	51.86	50.17	46.85	44.29	43.01	45.77	46.53	46.58	46.29
0.1	0.12	0.11	3.49	1.22	0.37	46.11	48.93	54.1	62.29	66.52	66.31	66.9	68.35	66.52	72.12	64.53	61.58	57.41	57.03	51.63	49.44	50.17	51.41	59.54	0	0	0
0.19	0.49	0.31	1.7	0.13	0.02	4.84	2.19	2.04	8.85	10.93	9.23	12.42	12.03	12.06	13.64	7.31	6.57	6.87	6.15	6.13	3.93	4.72	5.32	9.09	4.79	4.92	5.21
-	158.64	-37.45	450.16	-92.18	-84.96	24,110.00	-54.79	-6.94	334.36	23.50	-15.52	34.57	-3.20	0.32	13.06	-46.44	-10.01	4.49	-10.48	-0.31	-35.86	20.12	12.68	70.73	-47.26	2.71	5.79
-	-	-	-	-	20.00	20.00	35.00	11.50	19.00	50.00	45.00	45.00	50.00	62.00	52.00	58.00	58.00	68.00	75.00	75.00	65.00	52.00	52.00	52.00	89.00	57.17	60.82
0	0	0	0	0	0	0	75	-67.14	65.22	163.16	-10	0	11.11	24	-16.13	11.54	0	17.24	10.29	0	-13.33	-20	0	0	71.15	-35.76	6.38
74	74	74	74	74	74	75	75	75	75	75	75	75	75	74.64	74.02	73.46	73.65	65.62	57.29	57.3	57.3	57.3	57.39	57.45	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Rechner

Screener

Insider Tracker

Dividend Calendar

Earnings Calendar

Economic Calendar

Macro Data

Ideas

Sectors

The Modern Financial Terminal

Trusted by leading companies and financial institutions

Kyorin Pharmaceutical Co Stock 4569.T

Price

Price

Ticker4569.T

ISINJP3247090008

Kyorin Pharmaceutical Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Kyorin Pharmaceutical Co Stock Price History

Kyorin Pharmaceutical Co Revenue, EBIT, Net Income

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Kyorin Pharmaceutical Co Revenue, EBIT and net profit per share

Kyorin Pharmaceutical Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Kyorin Pharmaceutical Co stock margins

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Kyorin Pharmaceutical Co Margin History

Kyorin Pharmaceutical Co Stock Sales Revenue, EBIT, Earnings per Share

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Kyorin Pharmaceutical Co Revenue, EBIT and net profit per share

Kyorin Pharmaceutical Co business model

Kyorin Pharmaceutical Co SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Kyorin Pharmaceutical Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Kyorin Pharmaceutical Co historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Kyorin Pharmaceutical Co shares outstanding

Revenue, EBIT and Earnings per share

Ticker
4569.T

ISIN
JP3247090008